BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26868017)

  • 1. Distinct genomic and epigenomic features demarcate hypomethylated blocks in colon cancer.
    Sharmin M; Bravo HC; Hannenhalli S
    BMC Cancer; 2016 Feb; 16():88. PubMed ID: 26868017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycomb repressive complex 2 epigenomic signature defines age-associated hypermethylation and gene expression changes.
    Dozmorov MG
    Epigenetics; 2015; 10(6):484-95. PubMed ID: 25880792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation regulates discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw mechanism.
    Sharifi-Zarchi A; Gerovska D; Adachi K; Totonchi M; Pezeshk H; Taft RJ; Schöler HR; Chitsaz H; Sadeghi M; Baharvand H; Araúzo-Bravo MJ
    BMC Genomics; 2017 Dec; 18(1):964. PubMed ID: 29233090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of DNA methylation in directing the functional organization of the cancer epigenome.
    Lay FD; Liu Y; Kelly TK; Witt H; Farnham PJ; Jones PA; Berman BP
    Genome Res; 2015 Apr; 25(4):467-77. PubMed ID: 25747664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using epigenomics data to predict gene expression in lung cancer.
    Li J; Ching T; Huang S; Garmire LX
    BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S10. PubMed ID: 25861082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer.
    Heyn H; Vidal E; Ferreira HJ; Vizoso M; Sayols S; Gomez A; Moran S; Boque-Sastre R; Guil S; Martinez-Cardus A; Lin CY; Royo R; Sanchez-Mut JV; Martinez R; Gut M; Torrents D; Orozco M; Gut I; Young RA; Esteller M
    Genome Biol; 2016 Jan; 17():11. PubMed ID: 26813288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct chromatin signatures of DNA hypomethylation in aging and cancer.
    Pérez RF; Tejedor JR; Bayón GF; Fernández AF; Fraga MF
    Aging Cell; 2018 Jun; 17(3):e12744. PubMed ID: 29504244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatin modifications and genomic contexts linked to dynamic DNA methylation patterns across human cell types.
    Yan H; Zhang D; Liu H; Wei Y; Lv J; Wang F; Zhang C; Wu Q; Su J; Zhang Y
    Sci Rep; 2015 Feb; 5():8410. PubMed ID: 25673498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orphan CpG islands define a novel class of highly active enhancers.
    Bell JSK; Vertino PM
    Epigenetics; 2017 Jun; 12(6):449-464. PubMed ID: 28448736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long range epigenetic silencing is a trans-species mechanism that results in cancer specific deregulation by overriding the chromatin domains of normal cells.
    Forn M; Muñoz M; Tauriello DV; Merlos-Suárez A; Rodilla V; Bigas A; Batlle E; Jordà M; Peinado MA
    Mol Oncol; 2013 Dec; 7(6):1129-41. PubMed ID: 24035705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenomic analysis reveals DNA motifs regulating histone modifications in human and mouse.
    Ngo V; Chen Z; Zhang K; Whitaker JW; Wang M; Wang W
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3668-3677. PubMed ID: 30755522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenome overlap measure (EPOM) for comparing tissue/cell types based on chromatin states.
    Li WV; Razaee ZS; Li JJ
    BMC Genomics; 2016 Jan; 17 Suppl 1(Suppl 1):10. PubMed ID: 26817822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-specific CpG 'beacons' identify human-specific prefrontal cortex H3K4me3 chromatin peaks.
    Bell CG; Wilson GA; Beck S
    Epigenomics; 2014 Feb; 6(1):21-31. PubMed ID: 24579944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of radiation-induced aberrant hypomethylation in colon cancer.
    Bae JH; Kim JG; Heo K; Yang K; Kim TO; Yi JM
    BMC Genomics; 2015 Feb; 16(1):56. PubMed ID: 25887185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleosomes are enriched at the boundaries of hypomethylated regions (HMRs) in mouse dermal fibroblasts and keratinocytes.
    He X; Chatterjee R; Tillo D; Smith A; FitzGerald P; Vinson C
    Epigenetics Chromatin; 2014; 7(1):34. PubMed ID: 25506399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased methylation variation in epigenetic domains across cancer types.
    Hansen KD; Timp W; Bravo HC; Sabunciyan S; Langmead B; McDonald OG; Wen B; Wu H; Liu Y; Diep D; Briem E; Zhang K; Irizarry RA; Feinberg AP
    Nat Genet; 2011 Jun; 43(8):768-75. PubMed ID: 21706001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large organized chromatin lysine domains help distinguish primitive from differentiated cell populations.
    Madani Tonekaboni SA; Haibe-Kains B; Lupien M
    Nat Commun; 2021 Jan; 12(1):499. PubMed ID: 33479238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating epigenomic data and 3D genomic structure with a new measure of chromatin assortativity.
    Pancaldi V; Carrillo-de-Santa-Pau E; Javierre BM; Juan D; Fraser P; Spivakov M; Valencia A; Rico D
    Genome Biol; 2016 Jul; 17(1):152. PubMed ID: 27391817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F; Wolffe AP
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic DNA methylation analysis of multiple cell lines reveals common and specific patterns within and across tissues of origin.
    Yang X; Shao X; Gao L; Zhang S
    Hum Mol Genet; 2015 Aug; 24(15):4374-84. PubMed ID: 25954028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.